Oncology Clinical Trials in San Francisco, CA

As of July 2026, 253 paid clinical trials are recruiting for Oncology in San Francisco, California. Oncology trials evaluate immunotherapies, targeted therapies, antibody-drug conjugates, and combination regimens across solid tumors and blood cancers — from early-phase first-in-human studies to phase 3 registration trials. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 17, 2026.

Filter results

Filter results

State

City

Facility

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

255 clinical trials for Oncology

·Clear filters·↓ Download CSV

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

for Prostate Adenocarcinoma

Sites in San Francisco, San Rafael +397 more locations

Sponsor: NRG Oncology

Sex: Male·Age: 18+

Code: NCT05946213·Phase 3·Recruiting·Listed Jul 2023

Apply to this trial

Immune Checkpoint Inhibitor Toxicity Risk Prediction in Solid Tumors

for Malignant Solid Neoplasm

Sites in San Francisco, San Rafael +586 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT04871542·Recruiting·Listed May 2021

Apply to this trial

Testing the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Sites in San Francisco, San Mateo +207 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554406·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

Cognitive Training for Cancer Related Cognitive Impairment in Breast Cancer Survivors

for Breast Cancer

Sites in San Francisco, San Rafael +635 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18 - 100

Code: NCT05896189·Recruiting·Listed Jun 2023

Apply to this trial

Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy

for B Acute Lymphoblastic Leukemia

Sites in San Francisco, Oakland +186 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: 365 Days - 25

Code: NCT03959085·Phase 3·Recruiting·Listed May 2019

Apply to this trial

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in San Francisco, Los Angeles +162 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18 - 59

Code: NCT05554393·Phase 2·Recruiting·Listed Sep 2022

Apply to this trial

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

for Hematologic Malignancies

Sites in San Francisco, Stanford +111 more locations

Sponsor: Center for International Blood and Marrow Transplant Research

Sex: All·Age: All ages

Code: NCT01351545·Recruiting·Listed May 2011

Apply to this trial

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

for Acute Myeloid Leukemia

Sites in San Francisco, Oakland +169 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 21

Code: NCT04293562·Phase 3·Recruiting·Listed Mar 2020

Apply to this trial

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

for Acute Myeloid Leukemia

Sites in San Francisco, San Mateo +125 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: 18+

Code: NCT06672146·Phase 2·Recruiting·Listed Nov 2024

Apply to this trial

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for Acute Lymphoblastic Leukemia

Sites in San Francisco, Oakland +154 more locations

Sponsor: PedAL BCU, LLC

Sex: All·Age: Up to 22

Code: NCT04726241·Phase 1, Phase 2·Recruiting·Listed Jan 2021

Apply to this trial

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

for Ganglioneuroblastoma, Nodular

Sites in San Francisco, Oakland +151 more locations

Sponsor: National Cancer Institute (NCI)

Sex: All·Age: Up to 30

Code: NCT06172296·Phase 3·Recruiting·Listed Dec 2023

Apply to this trial

A Study of Tarlatamab for People With Prostate Cancer

for Metastatic Prostate Cancer

Drug: Tarlatamab

Sites in San Francisco, San Diego +8 more locations

Sponsor: Memorial Sloan Kettering Cancer Center

Sex: Male·Age: 18+

Code: NCT07111507·Phase 2·Recruiting·Listed Aug 2025

Apply to this trial

177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate Cancer

for Metastatic Prostate Cancer

1 location in San Francisco

Sponsor: University of California, San Francisco

Sex: Male·Age: 18+

Code: NCT07145177·Phase 1·Recruiting·Listed Aug 2025

Apply to this trial

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

for Lung Non-Small Cell Carcinoma

Sites in San Francisco, San Mateo +241 more locations

Sponsor: SWOG Cancer Research Network

Sex: All·Age: 18+

Code: NCT06116682·Phase 2·Recruiting·Listed Nov 2023

Apply to this trial

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

for Glioblastoma

Sites in San Francisco, Los Angeles +26 more locations

Sponsor: Global Coalition for Adaptive Research

Sex: All·Age: 18+

Code: NCT03970447·Phase 2, Phase 3·Recruiting·Listed May 2019

Apply to this trial

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

for Fallopian Tube Endometrioid Adenocarcinoma

Drug: Bevacizumab

Sites in San Francisco, San Rafael +643 more locations

Sponsor: NRG Oncology

Sex: All·Age: 18+

Code: NCT06580314·Phase 3·Recruiting·Listed Aug 2024

Apply to this trial

Childhood Cancer Survivor Study

for Cancer

Sites in San Francisco, Stanford +25 more locations

Sponsor: St. Jude Children's Research Hospital

Sex: All·Age: All ages·Accepts healthy volunteers

Code: NCT01120353·Recruiting·Listed May 2010

Apply to this trial

Project: Every Child for Younger Patients With Cancer

for Adrenal Gland Pheochromocytoma

Sites in San Francisco, Oakland +231 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 25

Code: NCT02402244·Recruiting·Listed Mar 2015

Apply to this trial

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

for Acute Myeloid Leukemia

Drug: Venetoclax

Sites in San Francisco, Long Beach +43 more locations

Sponsor: PedAL BCU, LLC

Sex: All·Age: 29 Days - 21

Code: NCT05183035·Phase 3·Recruiting·Listed Jan 2022

Apply to this trial

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

for Breast Carcinoma

Sites in San Francisco, San Rafael +462 more locations

Sponsor: Wake Forest University Health Sciences

Sex: All·Age: 18+

Code: NCT06418204·Recruiting·Listed May 2024

Apply to this trial

Trametinib and Everolimus for Treatment of Pediatric and Young Adult Patients With Recurrent Gliomas (PNOC021)

for Recurrent World Health Organization (WHO) Grade II Glioma

Drug: Trametinib

Sites in San Francisco, Los Angeles +13 more locations

Sponsor: University of California, San Francisco

Sex: All·Age: 1 - 25

Code: NCT04485559·Phase 1·Recruiting·Listed Jul 2020

Apply to this trial

A Study to Compare Two Surgical Procedures in Individuals With BRCA1 Mutations to Assess Reduced Risk of Ovarian Cancer

for Ovarian Carcinoma

Sites in San Francisco, San Rafael +471 more locations

Sponsor: NRG Oncology

Sex: Female·Age: 35 - 50

Code: NCT04251052·Recruiting·Listed Jan 2020

Apply to this trial

Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma

for Metastatic Malignant Neoplasm in the Lung

Sites in San Francisco, Oakland +209 more locations

Sponsor: Children's Oncology Group

Sex: All·Age: Up to 50

Code: NCT05235165·Phase 3·Recruiting·Listed Feb 2022

Apply to this trial

Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer

for Ovarian Cancer

Sites in San Francisco +8 more locations

Sponsor: University of Alabama at Birmingham

Sex: Female·Age: 18+

Code: NCT04606914·Phase 2·Recruiting·Listed Oct 2020

Apply to this trial

I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

for Breast Neoplasms

Sites in San Francisco, Davis +31 more locations

Sponsor: QuantumLeap Healthcare Collaborative

Sex: All·Age: 18+

Code: NCT01042379·Phase 2·Recruiting·Listed Jan 2010

Apply to this trial

NANT 2021-01 Phase II STING (Sequential Temozolomide, Irinotecan, NK Cells and GD2 mAb) Trial

for Neuroblastoma

Drug: Irinotecan

Sites in San Francisco, Los Angeles +11 more locations

Sponsor: New Approaches to Neuroblastoma Therapy Consortium

Sex: All·Age: 1 - 31

Code: NCT06450041·Phase 2·Recruiting·Listed Jun 2024

Apply to this trial

Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies

for Non-small Cell Lung Cancer

Sites in San Francisco, Los Angeles +18 more locations

Sponsor: Institut de Recherches Internationales Servier

Sex: All·Age: 18+

Code: NCT05786924·Phase 1, Phase 2·Recruiting·Listed Mar 2023

Apply to this trial

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

for Metastatic Breast Cancer

Sites in San Francisco, San Diego +2 more locations

Sponsor: University of California, San Francisco

Sex: All·Age: 18+

Code: NCT05964504·Recruiting·Listed Jul 2023

Apply to this trial

Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer

for Thyroid Cancer

1 location in San Francisco

Sponsor: Thomas Hope

Sex: All·Age: 13+

Code: NCT06961084·Phase 2·Recruiting·Listed May 2025

Apply to this trial

Predicting BCG Response

for Bladder Cancer

Sites in San Francisco, Los Angeles +2 more locations

Sponsor: Cedars-Sinai Medical Center

Sex: All·Age: 18 - 90

Code: NCT04564781·Recruiting·Listed Sep 2020

Apply to this trial

Pancreatic Cancer Early Detection Consortium

for Pancreas Cancer

Sites in San Francisco, Sacramento +41 more locations

Sponsor: Arbor Research Collaborative for Health

Sex: All·Age: 18 - 90·Accepts healthy volunteers

Code: NCT04970056·Recruiting·Listed Jul 2021

Apply to this trial

Collecting Blood and Stool Samples to Detect Colorectal Cancer or Advanced Neoplasia in Lynch Syndrome Patients

for Colorectal Carcinoma

Sites in San Francisco +8 more locations

Sponsor: Mayo Clinic

Sex: All·Age: 18+

Code: NCT05410977·Recruiting·Listed Jun 2022

Apply to this trial

Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma

for Refractory Non-Hodgkin Lymphoma

1 location in San Francisco

Sponsor: C. Babis Andreadis

Sex: All·Age: 18+

Code: NCT04545762·Phase 1·Recruiting·Listed Sep 2020

Apply to this trial

Hyperpolarized Imaging in Diagnosing Participants With Glioma

for Glioma

1 location in San Francisco

Sponsor: Susan Chang

Sex: All·Age: 19+

Code: NCT03739411·Phase 1·Recruiting·Listed Nov 2018

Apply to this trial

Combination Therapy in Cancers With Mutations in DNA Repair Genes

for Metastatic Solid Tumor

1 location in San Francisco

Sponsor: University of California, San Francisco

Sex: All·Age: 18+

Code: NCT05694715·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

Hippocampal Avoidance in Craniospinal Irradiation for the Treatment of Leptomeningeal Metastases From Breast Cancer or Non-small Cell Lung Cancer

for Anatomic Stage IV Breast Cancer AJCC v8

Sites in San Francisco +1 more location

Sponsor: University of Washington

Sex: All·Age: 18+

Code: NCT06518057·Phase 2·Recruiting·Listed Jul 2024

Apply to this trial

ATEMPT 2.0: Adjuvant T-DM1 vs TH

for Breast Cancer

Sites in San Francisco +46 more locations

Sponsor: Dana-Farber Cancer Institute

Sex: All·Age: 18+

Code: NCT04893109·Phase 2·Recruiting·Listed May 2021

Apply to this trial

Imaging Study of [89Zr]DFO-YS5 for Detecting CD46 Positive Malignancy in Multiple Myeloma

for Multiple Myeloma

1 location in San Francisco

Sponsor: Robert Flavell, MD, PhD

Sex: All·Age: 18+

Code: NCT05892393·Phase 1·Recruiting·Listed Jun 2023

Apply to this trial

CONNECTing to LungCare

for Smoking Cessation

1 location in San Francisco

Sponsor: University of California, San Francisco

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT06213532·Recruiting·Listed Jan 2024

Apply to this trial

PET [89Zr]DFO-starPEG in Solid Tumors

for Solid Tumor

1 location in San Francisco

Sponsor: Robert Flavell, MD, PhD

Sex: All·Age: 18+

Code: NCT06894745·Phase 1·Recruiting·Listed Mar 2025

Apply to this trial

Conditions in Oncology (San Francisco, CA)

Solid tumor· 46 Prostate cancer· 31 Breast cancer· 29 Non-small cell lung cancer (NSCLC)· 28 Cancer (any)· 19 Glioblastoma· 17 Colorectal cancer· 15 Metastatic prostate cancer· 15 Metastatic breast cancer· 13 Bladder cancer· 13 Melanoma· 13 Acute myeloid leukemia (AML)· 12 Ovarian cancer· 11 Multiple myeloma· 11 Non-Hodgkin lymphoma· 10 Pancreatic cancer· 9 Neuroblastoma· 8 Liver cancer· 7 Endometrial cancer· 7 Glioma· 7 Hematologic malignancy· 7 Kidney cancer· 6 Brain cancer· 6 Leukemia (other)· 6 Head and neck cancer· 6 Pediatric cancer· 6 Triple-negative breast cancer· 5 Cervical cancer· 5 Follicular lymphoma· 5 HER2-negative breast cancer· 4 Gastric cancer· 4 Fallopian tube cancer· 4 Myelodysplastic syndromes (MDS)· 4 Diffuse large B-cell lymphoma (DLBCL)· 4 Mantle cell lymphoma· 4 Neuroendocrine tumors· 4 Lung cancer· 3 Biliary tract cancer· 3 Gynecologic cancer· 3 Thyroid cancer· 3 HER2-positive breast cancer· 2 Colon cancer· 2 Uterine cancer· 2 Chronic lymphocytic leukemia (CLL)· 2 Acute lymphoblastic leukemia· 2 Myeloproliferative neoplasm· 2 Hodgkin lymphoma· 2 Small lymphocytic lymphoma· 2 Skin cancer· 2 Osteosarcoma· 2 Ewing sarcoma· 2 Small cell lung cancer· 1 Metastatic colorectal cancer· 1 Rectal cancer· 1 Esophageal cancer· 1 Gastroesophageal junction cancer· 1 Gastrointestinal cancer· 1 Brain metastases· 1 Myelofibrosis· 1 Marginal zone lymphoma· 1 Burkitt lymphoma· 1 Soft tissue sarcoma· 1 Rhabdomyosarcoma· 1 Mesothelioma· 1